SlideShare a Scribd company logo
W
QUALITY CONTROL
Human high sensitivity control material to
facilitate quality assurance of biochemical
tests for cardiac troponin T
Wong W-Y., Shanks A., Spon-Smith C., Rodríguez M.L., Campbell J., FitzGerald S.P.
Randox Laboratories Limited
Diamond Road, Crumlin, County Antrim, N. Ireland, BT29 4QY, United Kingdom.
The human control material contained cTnT at levels around the cut-off of 14 ng/L
Reconstituted open vial stability over 5 days at +2°C to +8°C
Analyte Day 0 Day 1 % Recovery from Day 0 Day 0 Day 4 % Recovery from Day 0 Day 0 Day 5 % Recovery from Day 0
cTnT (ng/L) 19.16 18.73 98 17.82 18.79 105 20.34 19.59 104
Analyte Day 0 Day 3 % Recovery from Day 0 Day 0 Day 4 % Recovery from Day 0 Day 0 Day 5 % Recovery from Day 0
cTnT (ng/L) 21.14 20.64 98 19.46 19.42 100 20.31 20.02 99
Reconstituted open vial stability over 5 days at +2°C to +8°C after 4 weeks at -20°C
Analyte Lyophilised -80°C Lyophilised 4 years +2°C to +8°C % Recovery
cTnT (ng/L) 19.6 19.2 98
Shelf life stability
cTnT levels
Results
Introduction
In the diagnosis of myocardial infarction an increased value of cardiac troponin in blood is
defined as a measurement exceeding the 99th
percentile of a normal reference population
and at this percentile the optimal precision should be defined as <10%.1
The monitoring
of the accuracy and precision of the biochemical tests for cardiac troponin require quality
control material.This study reports a human control material for cardiac troponin
T (cTnT) presenting values allowing the assessment of the analytical performance at
the low end of the assay range which is also advantageous for the earlier detection of
cTnT.
Methodology
The human control material contained cTnT at levels around the cut-off of 14 ng/L and
was dispensed into 3 mL glass vials and lyophilised.
Reconstitutedstabilityandreconstitutedstabilityafterfreezingweredeterminedrespectively
as the %recovery of cTnT over a period of 5 days when stored at +2°C to +8°C related
to day 0 (+2°C to +8°C) and a period of 5 days when stored at +2°C to +8°C after 4
weeks at -20°C related to day 0. Shelf life was determined as the %recovery of cTnT from
lyophilised material stored at +2°C to +8°C over a period of 4 years related to material
stored at -80°C.
Conclusion
The human lyophilised high sensitivity troponin T control with target values around the
cut-off 14 ng/L presented reconstituted stability of 5 days (+2°C to +8°C) and 4 weeks
(-20°C).Shelf life was determined as 4 years.This control material is suitable for monitoring
the performance of high sensitivity troponin T assays facilitating earlier detection of this
biomarker.
Randox Laboratories Limited, 55 Diamond Road, Crumlin, County Antrim, BT29 4QY, United Kingdom
+44 (0) 28 9442 2413 +44 (0) 28 9445 2912 marketing@randox.com randoxqc.com
QUALITY CONTROL
For more information
please visit booth number 7
Reference
1.	 Thygesen K,Alpert JS,White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur.Heart J. 2007, 28(20): 2525-2538.
Complete QC solutions for results you can trust
13/051/622RDS
13/050/622RDS
14/063/622RDS

More Related Content

Viewers also liked

New summary interlaboratory & summary instrument group reports mar15 svk
New summary interlaboratory & summary instrument group reports mar15 svkNew summary interlaboratory & summary instrument group reports mar15 svk
New summary interlaboratory & summary instrument group reports mar15 svk
Randox
 
Uso de Multireglas CC
Uso de Multireglas CCUso de Multireglas CC
Uso de Multireglas CC
Randox
 
Consolidate & Save
Consolidate & SaveConsolidate & Save
Consolidate & Save
Randox
 
New summary interlaboratory & summary instrument group reports mar15 rus
New summary interlaboratory & summary instrument group reports mar15 rusNew summary interlaboratory & summary instrument group reports mar15 rus
New summary interlaboratory & summary instrument group reports mar15 rus
Randox
 
New summary interlaboratory & summary instrument group reports mar15 prt
New summary interlaboratory & summary instrument group reports mar15 prtNew summary interlaboratory & summary instrument group reports mar15 prt
New summary interlaboratory & summary instrument group reports mar15 prt
Randox
 
Guide to running QC
Guide to running QCGuide to running QC
Guide to running QC
Randox
 
The Importance of Third Party Controls
The Importance of Third Party ControlsThe Importance of Third Party Controls
The Importance of Third Party Controls
Randox
 
Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...
Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...
Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...
Randox
 
QC Multi rules - Improving Laboratory Performance Through Quality Control
QC Multi rules - Improving Laboratory Performance Through Quality ControlQC Multi rules - Improving Laboratory Performance Through Quality Control
QC Multi rules - Improving Laboratory Performance Through Quality Control
Randox
 
What format is best for your laboratory
What format is best for your laboratoryWhat format is best for your laboratory
What format is best for your laboratory
Randox
 
Improving Laboratory Performance Through QC - Commutability
Improving Laboratory Performance Through QC - CommutabilityImproving Laboratory Performance Through QC - Commutability
Improving Laboratory Performance Through QC - Commutability
Randox
 
Using QC Multi-rules
Using QC Multi-rulesUsing QC Multi-rules
Using QC Multi-rules
Randox
 
Quality Control for Point of Care Testing - White Paper
Quality Control for Point of Care Testing - White PaperQuality Control for Point of Care Testing - White Paper
Quality Control for Point of Care Testing - White Paper
Randox
 
White Paper Quality Control for Point of Care Testing
White Paper Quality Control for Point of Care TestingWhite Paper Quality Control for Point of Care Testing
White Paper Quality Control for Point of Care Testing
Randox
 
Step by Step Guide to Preparing QC
Step by Step Guide to Preparing QCStep by Step Guide to Preparing QC
Step by Step Guide to Preparing QC
Randox
 
Acusera Verify Presentation
Acusera Verify PresentationAcusera Verify Presentation
Acusera Verify Presentation
Randox
 
EQA: An Essential Tool for Laboratory Quality - Africa LT649
EQA: An Essential Tool for Laboratory Quality - Africa LT649 EQA: An Essential Tool for Laboratory Quality - Africa LT649
EQA: An Essential Tool for Laboratory Quality - Africa LT649
Randox
 

Viewers also liked (17)

New summary interlaboratory & summary instrument group reports mar15 svk
New summary interlaboratory & summary instrument group reports mar15 svkNew summary interlaboratory & summary instrument group reports mar15 svk
New summary interlaboratory & summary instrument group reports mar15 svk
 
Uso de Multireglas CC
Uso de Multireglas CCUso de Multireglas CC
Uso de Multireglas CC
 
Consolidate & Save
Consolidate & SaveConsolidate & Save
Consolidate & Save
 
New summary interlaboratory & summary instrument group reports mar15 rus
New summary interlaboratory & summary instrument group reports mar15 rusNew summary interlaboratory & summary instrument group reports mar15 rus
New summary interlaboratory & summary instrument group reports mar15 rus
 
New summary interlaboratory & summary instrument group reports mar15 prt
New summary interlaboratory & summary instrument group reports mar15 prtNew summary interlaboratory & summary instrument group reports mar15 prt
New summary interlaboratory & summary instrument group reports mar15 prt
 
Guide to running QC
Guide to running QCGuide to running QC
Guide to running QC
 
The Importance of Third Party Controls
The Importance of Third Party ControlsThe Importance of Third Party Controls
The Importance of Third Party Controls
 
Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...
Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...
Basic QC Statistics - Improving Laboratory Performance Through Quality Contro...
 
QC Multi rules - Improving Laboratory Performance Through Quality Control
QC Multi rules - Improving Laboratory Performance Through Quality ControlQC Multi rules - Improving Laboratory Performance Through Quality Control
QC Multi rules - Improving Laboratory Performance Through Quality Control
 
What format is best for your laboratory
What format is best for your laboratoryWhat format is best for your laboratory
What format is best for your laboratory
 
Improving Laboratory Performance Through QC - Commutability
Improving Laboratory Performance Through QC - CommutabilityImproving Laboratory Performance Through QC - Commutability
Improving Laboratory Performance Through QC - Commutability
 
Using QC Multi-rules
Using QC Multi-rulesUsing QC Multi-rules
Using QC Multi-rules
 
Quality Control for Point of Care Testing - White Paper
Quality Control for Point of Care Testing - White PaperQuality Control for Point of Care Testing - White Paper
Quality Control for Point of Care Testing - White Paper
 
White Paper Quality Control for Point of Care Testing
White Paper Quality Control for Point of Care TestingWhite Paper Quality Control for Point of Care Testing
White Paper Quality Control for Point of Care Testing
 
Step by Step Guide to Preparing QC
Step by Step Guide to Preparing QCStep by Step Guide to Preparing QC
Step by Step Guide to Preparing QC
 
Acusera Verify Presentation
Acusera Verify PresentationAcusera Verify Presentation
Acusera Verify Presentation
 
EQA: An Essential Tool for Laboratory Quality - Africa LT649
EQA: An Essential Tool for Laboratory Quality - Africa LT649 EQA: An Essential Tool for Laboratory Quality - Africa LT649
EQA: An Essential Tool for Laboratory Quality - Africa LT649
 

Similar to ACB Focus 2015 Poster

ICH Guideline for Drug Stability
ICH Guideline for Drug StabilityICH Guideline for Drug Stability
ICH Guideline for Drug Stability
Eknath6
 
ICH Stability Testing Guidelines ONline 9-5-24.pdf
ICH Stability Testing Guidelines ONline 9-5-24.pdfICH Stability Testing Guidelines ONline 9-5-24.pdf
ICH Stability Testing Guidelines ONline 9-5-24.pdf
Dr. Yuppie Rajasekhar Poonuru
 
ICH Stability testing of new drug substances and products QA (R2) - 2015
ICH Stability testing of new drug substances and products QA (R2) - 2015ICH Stability testing of new drug substances and products QA (R2) - 2015
ICH Stability testing of new drug substances and products QA (R2) - 2015
Pharmaceutical Compliance Inspection unit, Crown College of Canada
 
Dry powder, Meter dose and Nebulizer inhaler
Dry powder, Meter dose and Nebulizer inhalerDry powder, Meter dose and Nebulizer inhaler
Dry powder, Meter dose and Nebulizer inhaler
Yogesh Chaudhari
 
Stability testing
Stability testingStability testing
Stability testingGaurav Kr
 
Shelf life-study-webinar-slides-102815
Shelf life-study-webinar-slides-102815Shelf life-study-webinar-slides-102815
Shelf life-study-webinar-slides-102815
Teju Murthy J S
 
Power point presentation shweta patil.
Power point presentation shweta patil.Power point presentation shweta patil.
Power point presentation shweta patil.ceutics1315
 
New microsoft office power point presentation (4)
New microsoft office power point presentation (4)New microsoft office power point presentation (4)
New microsoft office power point presentation (4)
SrinivasaReddy137
 
Seminor on accelerated stability testing of dosage forms sahil
Seminor on accelerated stability testing of dosage forms sahilSeminor on accelerated stability testing of dosage forms sahil
Seminor on accelerated stability testing of dosage forms sahilsahilhusen
 
Seminor on accelerated stability testing of dosage forms sahil
Seminor on accelerated stability testing of dosage forms sahilSeminor on accelerated stability testing of dosage forms sahil
Seminor on accelerated stability testing of dosage forms sahilsahilhusen
 
STABILITY TESTING OF HERBAL NATURAL PRODUCTS AND ITS PROTOCOL.pptx
STABILITY TESTING OF HERBAL NATURAL PRODUCTS AND ITS PROTOCOL.pptxSTABILITY TESTING OF HERBAL NATURAL PRODUCTS AND ITS PROTOCOL.pptx
STABILITY TESTING OF HERBAL NATURAL PRODUCTS AND ITS PROTOCOL.pptx
NEW ROYAL CARE PHARMACY, SALEM, TAMILNADU, INDIA - 636011
 
Ich guidelines for stability studies 2
Ich guidelines for stability studies 2Ich guidelines for stability studies 2
Ich guidelines for stability studies 2
priyanka odela
 
Stability testing of herbal natural products and its
Stability testing of herbal natural products and itsStability testing of herbal natural products and its
Stability testing of herbal natural products and its
SudhindraKini
 
Accelerated stability studes
Accelerated stability studesAccelerated stability studes
Accelerated stability studesSunil Boreddy Rx
 
Stability testing and shelf life estimation
Stability testing and shelf life estimationStability testing and shelf life estimation
Stability testing and shelf life estimation
Manish sharma
 
Stability studies
Stability studiesStability studies
Stability studies
shaik malangsha
 
Stability Testing.pptx
Stability Testing.pptxStability Testing.pptx
Stability Testing.pptx
SunaynaChoudhary
 
Q1A(R2): STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS
Q1A(R2): STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTSQ1A(R2): STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS
Q1A(R2): STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS
Bhaumik Bavishi
 

Similar to ACB Focus 2015 Poster (20)

ICH Guideline for Drug Stability
ICH Guideline for Drug StabilityICH Guideline for Drug Stability
ICH Guideline for Drug Stability
 
ICH Stability Testing Guidelines ONline 9-5-24.pdf
ICH Stability Testing Guidelines ONline 9-5-24.pdfICH Stability Testing Guidelines ONline 9-5-24.pdf
ICH Stability Testing Guidelines ONline 9-5-24.pdf
 
ICH Stability testing of new drug substances and products QA (R2) - 2015
ICH Stability testing of new drug substances and products QA (R2) - 2015ICH Stability testing of new drug substances and products QA (R2) - 2015
ICH Stability testing of new drug substances and products QA (R2) - 2015
 
Over View Of Stability Studies
Over View Of Stability StudiesOver View Of Stability Studies
Over View Of Stability Studies
 
Dry powder, Meter dose and Nebulizer inhaler
Dry powder, Meter dose and Nebulizer inhalerDry powder, Meter dose and Nebulizer inhaler
Dry powder, Meter dose and Nebulizer inhaler
 
Stability testing
Stability testingStability testing
Stability testing
 
Shelf life-study-webinar-slides-102815
Shelf life-study-webinar-slides-102815Shelf life-study-webinar-slides-102815
Shelf life-study-webinar-slides-102815
 
Power point presentation shweta patil.
Power point presentation shweta patil.Power point presentation shweta patil.
Power point presentation shweta patil.
 
Power point presentation shweta patil.
Power point presentation shweta patil.Power point presentation shweta patil.
Power point presentation shweta patil.
 
New microsoft office power point presentation (4)
New microsoft office power point presentation (4)New microsoft office power point presentation (4)
New microsoft office power point presentation (4)
 
Seminor on accelerated stability testing of dosage forms sahil
Seminor on accelerated stability testing of dosage forms sahilSeminor on accelerated stability testing of dosage forms sahil
Seminor on accelerated stability testing of dosage forms sahil
 
Seminor on accelerated stability testing of dosage forms sahil
Seminor on accelerated stability testing of dosage forms sahilSeminor on accelerated stability testing of dosage forms sahil
Seminor on accelerated stability testing of dosage forms sahil
 
STABILITY TESTING OF HERBAL NATURAL PRODUCTS AND ITS PROTOCOL.pptx
STABILITY TESTING OF HERBAL NATURAL PRODUCTS AND ITS PROTOCOL.pptxSTABILITY TESTING OF HERBAL NATURAL PRODUCTS AND ITS PROTOCOL.pptx
STABILITY TESTING OF HERBAL NATURAL PRODUCTS AND ITS PROTOCOL.pptx
 
Ich guidelines for stability studies 2
Ich guidelines for stability studies 2Ich guidelines for stability studies 2
Ich guidelines for stability studies 2
 
Stability testing of herbal natural products and its
Stability testing of herbal natural products and itsStability testing of herbal natural products and its
Stability testing of herbal natural products and its
 
Accelerated stability studes
Accelerated stability studesAccelerated stability studes
Accelerated stability studes
 
Stability testing and shelf life estimation
Stability testing and shelf life estimationStability testing and shelf life estimation
Stability testing and shelf life estimation
 
Stability studies
Stability studiesStability studies
Stability studies
 
Stability Testing.pptx
Stability Testing.pptxStability Testing.pptx
Stability Testing.pptx
 
Q1A(R2): STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS
Q1A(R2): STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTSQ1A(R2): STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS
Q1A(R2): STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS
 

More from Randox

How to establish QC reference ranges - Randox QC Educational Guide
How to establish QC reference ranges - Randox QC Educational GuideHow to establish QC reference ranges - Randox QC Educational Guide
How to establish QC reference ranges - Randox QC Educational Guide
Randox
 
Acusera Third Party Controls
Acusera Third Party ControlsAcusera Third Party Controls
Acusera Third Party Controls
Randox
 
Acusera 24.7 QC Data Management
Acusera 24.7 QC Data ManagementAcusera 24.7 QC Data Management
Acusera 24.7 QC Data Management
Randox
 
Acusera 24.7 Interlaboratory Data Management - June 17 LT244
Acusera 24.7 Interlaboratory Data Management - June 17 LT244Acusera 24.7 Interlaboratory Data Management - June 17 LT244
Acusera 24.7 Interlaboratory Data Management - June 17 LT244
Randox
 
Acusera Verify Linearity Verification - June 17 LT674
Acusera Verify Linearity Verification - June 17 LT674Acusera Verify Linearity Verification - June 17 LT674
Acusera Verify Linearity Verification - June 17 LT674
Randox
 
LT033 RIQAS Explained MAY17
LT033 RIQAS Explained MAY17LT033 RIQAS Explained MAY17
LT033 RIQAS Explained MAY17
Randox
 
LT027 Acusera Third Party Controls May17
LT027 Acusera Third Party Controls May17LT027 Acusera Third Party Controls May17
LT027 Acusera Third Party Controls May17
Randox
 
RIQAS Calendar 2017
RIQAS Calendar 2017RIQAS Calendar 2017
RIQAS Calendar 2017
Randox
 
ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...
ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...
ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...
Randox
 
FOCUS 2016 Poster: Specific Proteins
FOCUS 2016 Poster: Specific ProteinsFOCUS 2016 Poster: Specific Proteins
FOCUS 2016 Poster: Specific Proteins
Randox
 
How to Measure Uncertainty
How to Measure UncertaintyHow to Measure Uncertainty
How to Measure Uncertainty
Randox
 
Troubleshooting QC Problems: Your QC has failed, what do you do next?
Troubleshooting QC Problems: Your QC has failed, what do you do next?Troubleshooting QC Problems: Your QC has failed, what do you do next?
Troubleshooting QC Problems: Your QC has failed, what do you do next?
Randox
 
Monitoring EQA/PT Performance (Polish)
Monitoring EQA/PT Performance (Polish)Monitoring EQA/PT Performance (Polish)
Monitoring EQA/PT Performance (Polish)
Randox
 
Improving Laboratory Performance Through Quality Control - The role of EQA in...
Improving Laboratory Performance Through Quality Control - The role of EQA in...Improving Laboratory Performance Through Quality Control - The role of EQA in...
Improving Laboratory Performance Through Quality Control - The role of EQA in...
Randox
 

More from Randox (14)

How to establish QC reference ranges - Randox QC Educational Guide
How to establish QC reference ranges - Randox QC Educational GuideHow to establish QC reference ranges - Randox QC Educational Guide
How to establish QC reference ranges - Randox QC Educational Guide
 
Acusera Third Party Controls
Acusera Third Party ControlsAcusera Third Party Controls
Acusera Third Party Controls
 
Acusera 24.7 QC Data Management
Acusera 24.7 QC Data ManagementAcusera 24.7 QC Data Management
Acusera 24.7 QC Data Management
 
Acusera 24.7 Interlaboratory Data Management - June 17 LT244
Acusera 24.7 Interlaboratory Data Management - June 17 LT244Acusera 24.7 Interlaboratory Data Management - June 17 LT244
Acusera 24.7 Interlaboratory Data Management - June 17 LT244
 
Acusera Verify Linearity Verification - June 17 LT674
Acusera Verify Linearity Verification - June 17 LT674Acusera Verify Linearity Verification - June 17 LT674
Acusera Verify Linearity Verification - June 17 LT674
 
LT033 RIQAS Explained MAY17
LT033 RIQAS Explained MAY17LT033 RIQAS Explained MAY17
LT033 RIQAS Explained MAY17
 
LT027 Acusera Third Party Controls May17
LT027 Acusera Third Party Controls May17LT027 Acusera Third Party Controls May17
LT027 Acusera Third Party Controls May17
 
RIQAS Calendar 2017
RIQAS Calendar 2017RIQAS Calendar 2017
RIQAS Calendar 2017
 
ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...
ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...
ISO 15189 Accreditation Guide - Improving Laboratory Performance Through Qual...
 
FOCUS 2016 Poster: Specific Proteins
FOCUS 2016 Poster: Specific ProteinsFOCUS 2016 Poster: Specific Proteins
FOCUS 2016 Poster: Specific Proteins
 
How to Measure Uncertainty
How to Measure UncertaintyHow to Measure Uncertainty
How to Measure Uncertainty
 
Troubleshooting QC Problems: Your QC has failed, what do you do next?
Troubleshooting QC Problems: Your QC has failed, what do you do next?Troubleshooting QC Problems: Your QC has failed, what do you do next?
Troubleshooting QC Problems: Your QC has failed, what do you do next?
 
Monitoring EQA/PT Performance (Polish)
Monitoring EQA/PT Performance (Polish)Monitoring EQA/PT Performance (Polish)
Monitoring EQA/PT Performance (Polish)
 
Improving Laboratory Performance Through Quality Control - The role of EQA in...
Improving Laboratory Performance Through Quality Control - The role of EQA in...Improving Laboratory Performance Through Quality Control - The role of EQA in...
Improving Laboratory Performance Through Quality Control - The role of EQA in...
 

Recently uploaded

Trauma Outpatient Center .
Trauma Outpatient Center                       .Trauma Outpatient Center                       .
Trauma Outpatient Center .
TraumaOutpatientCent
 
The positive impact of SGRT – The Berkshire Cancer Centre experience
The positive impact of SGRT – The Berkshire Cancer Centre experienceThe positive impact of SGRT – The Berkshire Cancer Centre experience
The positive impact of SGRT – The Berkshire Cancer Centre experience
SGRT Community
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
Canadian Cancer Survivor Network
 
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
nirahealhty
 
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
blessyjannu21
 
Nursing education curriculum development.pptx
Nursing education curriculum development.pptxNursing education curriculum development.pptx
Nursing education curriculum development.pptx
sadhanajagtap3
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
VITASAuthor
 
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSONNEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
SHAMIN EABENSON
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DR Jag Mohan Prajapati
 
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
khvdq584
 
NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022
nktiacc3
 
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsxChild Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Sankalpa Gunathilaka
 
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COMHUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
priyabhojwani1200
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
Brian Frerichs
 
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Levi Shapiro
 
KEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docxKEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docx
NX Healthcare
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
Rajarambapu College of Pharmacy Kasegaon Dist Sangli
 
Top Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima SpaTop Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima Spa
Chandrima Spa Ajman
 
Luxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage CenterLuxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage Center
Chandrima Spa Ajman
 
Gemma Wean- Nutritional solution for Artemia
Gemma Wean- Nutritional solution for ArtemiaGemma Wean- Nutritional solution for Artemia
Gemma Wean- Nutritional solution for Artemia
smuskaan0008
 

Recently uploaded (20)

Trauma Outpatient Center .
Trauma Outpatient Center                       .Trauma Outpatient Center                       .
Trauma Outpatient Center .
 
The positive impact of SGRT – The Berkshire Cancer Centre experience
The positive impact of SGRT – The Berkshire Cancer Centre experienceThe positive impact of SGRT – The Berkshire Cancer Centre experience
The positive impact of SGRT – The Berkshire Cancer Centre experience
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
 
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
 
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)
 
Nursing education curriculum development.pptx
Nursing education curriculum development.pptxNursing education curriculum development.pptx
Nursing education curriculum development.pptx
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
 
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSONNEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
 
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
 
NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022
 
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsxChild Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
 
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COMHUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
 
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...
 
KEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docxKEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docx
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
 
Top Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima SpaTop Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima Spa
 
Luxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage CenterLuxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage Center
 
Gemma Wean- Nutritional solution for Artemia
Gemma Wean- Nutritional solution for ArtemiaGemma Wean- Nutritional solution for Artemia
Gemma Wean- Nutritional solution for Artemia
 

ACB Focus 2015 Poster

  • 1. W QUALITY CONTROL Human high sensitivity control material to facilitate quality assurance of biochemical tests for cardiac troponin T Wong W-Y., Shanks A., Spon-Smith C., Rodríguez M.L., Campbell J., FitzGerald S.P. Randox Laboratories Limited Diamond Road, Crumlin, County Antrim, N. Ireland, BT29 4QY, United Kingdom. The human control material contained cTnT at levels around the cut-off of 14 ng/L Reconstituted open vial stability over 5 days at +2°C to +8°C Analyte Day 0 Day 1 % Recovery from Day 0 Day 0 Day 4 % Recovery from Day 0 Day 0 Day 5 % Recovery from Day 0 cTnT (ng/L) 19.16 18.73 98 17.82 18.79 105 20.34 19.59 104 Analyte Day 0 Day 3 % Recovery from Day 0 Day 0 Day 4 % Recovery from Day 0 Day 0 Day 5 % Recovery from Day 0 cTnT (ng/L) 21.14 20.64 98 19.46 19.42 100 20.31 20.02 99 Reconstituted open vial stability over 5 days at +2°C to +8°C after 4 weeks at -20°C Analyte Lyophilised -80°C Lyophilised 4 years +2°C to +8°C % Recovery cTnT (ng/L) 19.6 19.2 98 Shelf life stability cTnT levels Results Introduction In the diagnosis of myocardial infarction an increased value of cardiac troponin in blood is defined as a measurement exceeding the 99th percentile of a normal reference population and at this percentile the optimal precision should be defined as <10%.1 The monitoring of the accuracy and precision of the biochemical tests for cardiac troponin require quality control material.This study reports a human control material for cardiac troponin T (cTnT) presenting values allowing the assessment of the analytical performance at the low end of the assay range which is also advantageous for the earlier detection of cTnT. Methodology The human control material contained cTnT at levels around the cut-off of 14 ng/L and was dispensed into 3 mL glass vials and lyophilised. Reconstitutedstabilityandreconstitutedstabilityafterfreezingweredeterminedrespectively as the %recovery of cTnT over a period of 5 days when stored at +2°C to +8°C related to day 0 (+2°C to +8°C) and a period of 5 days when stored at +2°C to +8°C after 4 weeks at -20°C related to day 0. Shelf life was determined as the %recovery of cTnT from lyophilised material stored at +2°C to +8°C over a period of 4 years related to material stored at -80°C. Conclusion The human lyophilised high sensitivity troponin T control with target values around the cut-off 14 ng/L presented reconstituted stability of 5 days (+2°C to +8°C) and 4 weeks (-20°C).Shelf life was determined as 4 years.This control material is suitable for monitoring the performance of high sensitivity troponin T assays facilitating earlier detection of this biomarker. Randox Laboratories Limited, 55 Diamond Road, Crumlin, County Antrim, BT29 4QY, United Kingdom +44 (0) 28 9442 2413 +44 (0) 28 9445 2912 marketing@randox.com randoxqc.com QUALITY CONTROL For more information please visit booth number 7 Reference 1. Thygesen K,Alpert JS,White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur.Heart J. 2007, 28(20): 2525-2538. Complete QC solutions for results you can trust 13/051/622RDS 13/050/622RDS 14/063/622RDS